Literature DB >> 25486553

A new inflammatory role for p53 in human macrophages.

Julie M Lowe1, Daniel Menendez, Michael B Fessler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25486553      PMCID： PMC4614039          DOI： 10.4161/15384101.2014.959852

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  5 in total

Review 1.  p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism.

Authors:  Prashanth Ak; Arnold J Levine
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

Review 2.  NFκB/p53 crosstalk-a promising new therapeutic target.

Authors:  Günter Schneider; Oliver H Krämer
Journal:  Biochim Biophys Acta       Date:  2010-10-15

Review 3.  Tumor associated macrophages and neutrophils in tumor progression.

Authors:  Maria R Galdiero; Cecilia Garlanda; Sébastien Jaillon; Gianni Marone; Alberto Mantovani
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

4.  Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.

Authors:  Katharine D Grugan; Francis L McCabe; Michelle Kinder; Allison R Greenplate; Benjamin C Harman; Jason E Ekert; Nico van Rooijen; G Mark Anderson; Jeffrey A Nemeth; William R Strohl; Robert E Jordan; Randall J Brezski
Journal:  J Immunol       Date:  2012-10-26       Impact factor: 5.422

5.  p53 and NF-κB coregulate proinflammatory gene responses in human macrophages.

Authors:  Julie M Lowe; Daniel Menendez; Pierre R Bushel; Maria Shatz; Erin L Kirk; Melissa A Troester; Stavros Garantziotis; Michael B Fessler; Michael A Resnick
Journal:  Cancer Res       Date:  2014-04-15       Impact factor: 12.701
  5 in total
  5 in total

1.  Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells.

Authors:  Kourosh Gharun; Julia Senges; Maximilian Seidl; Anne Lösslein; Julia Kolter; Florens Lohrmann; Manfred Fliegauf; Magdeldin Elgizouli; Marco Alber; Martina Vavra; Kristina Schachtrup; Anna L Illert; Martine Gilleron; Carsten J Kirschning; Antigoni Triantafyllopoulou; Philipp Henneke
Journal:  EMBO Rep       Date:  2017-11-02       Impact factor: 8.807

Review 2.  Oncogenes in immune cells as potential therapeutic targets.

Authors:  Gulnur K Zakiryanova; Sarah Wheeler; Michael R Shurin
Journal:  Immunotargets Ther       Date:  2018-04-11

Review 3.  Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.

Authors:  Lorenzo Stramucci; Angelina Pranteda; Gianluca Bossi
Journal:  Cancers (Basel)       Date:  2018-05-03       Impact factor: 6.639

4.  Anti-Inflammatory and Anti-Aging Evaluation of Pigment-Protein Complex Extracted from Chlorella Pyrenoidosa.

Authors:  Ruilin Zhang; Jian Chen; Xinwu Mao; Ping Qi; Xuewu Zhang
Journal:  Mar Drugs       Date:  2019-10-16       Impact factor: 5.118

5.  Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107.

Authors:  Robert Lodge; Nicolas Bellini; Mélanie Laporte; Syim Salahuddin; Jean-Pierre Routy; Petronela Ancuta; Cecilia T Costiniuk; Mohammad-Ali Jenabian; Éric A Cohen
Journal:  mBio       Date:  2020-09-29       Impact factor: 7.867
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.